Disclosure Panels Details Page
Genetic/Familial High-Risk Assessment: Colorectal Panel - Disclosures as of 12/06/2022
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| Lisen Axell MS | None | Natera | None | None | ✔ |
| Marian Birkeland PhD | None | None | None | None | - |
| Carol Burke MD | Emtora biosciences Freenome inc |
sebela | ambry | None | - |
| Lee-May Chen MD | AstraZeneca Pharmaceuticals LP Genentech, Inc. GSK |
None | None | None | ✔ |
| Daniel Chung MD | Immunovia Iterative Scopes Janssen Pharmaceutica Products, LP |
Guardant | None | None | ✔ |
| Katherine Clayback MS, CGC | None | None | None | None | ✔ |
| Susan Dallas | None | None | None | None | ✔ |
| Susan Darlow PhD | None | None | None | None | ✔ |
| Mary Dwyer MS | None | None | None | None | ✔ |
| Seth Felder MD | None | None | None | None | ✔ |
| Francis Giardiello MD, MBA | None | None | Steinberg Gastroenterology Board Review Course | None | ✔ |
| William Grady MD | Diacarta Janssen Pharmaceutica Products, LP Lucid Technologies Nephron Tempus |
Freenome Guardant Health Helio SEngine |
GLG WebMD |
None | ✔ |
| Kristina Gregory MSN, RN | None | None | None | None | - |
| Samir Gupta MD | Epigenomics Freenome |
Cellmax Geneoscopy Guardant Intervenn |
None | Cellmax LLC|Epigenomics|Freenome | ✔ |
| Michael Hall MD, MS | Caris Life Sciences Invitae Myriad Genetic Laboratories, Inc. |
Eisai Inc. GRAIL Natera |
None | None | ✔ |
| Heather Hampel MS, LGC | National Cancer Institute | 23andMe AIM Specialty Health Genome Medical GI OnDemand Natera |
None | None | ✔ |
| Rachel Hodan MS, CGC | None | None | None | None | ✔ |
| Gregory Idos MD, MS | None | None | None | None | ✔ |
| Nawal Kassem MD, MS | None | None | None | None | ✔ |
| Bryson Katona MD, PhD | Ambry Freenome GeneDx Guardant Immunovia Invitae Janssen Pharmaceutica Products, LP Universal Diagnostics |
None | None | None | ✔ |
| Laura Lamps MD | None | Scientific Symposiums International | None | United States and Canadian Academy of Pathology | ✔ |
| Xavier Llor MD, PhD | None | None | None | None | ✔ |
| Arnold Markowitz MD | None | None | None | None | ✔ |
| Mariana Niell-Swiller MS | None | None | None | None | ✔ |
| Darryl Outlaw MD | None | None | OncLive - Institutional Perspectives in Cancer: Gastrointestinal Malignancies | None | ✔ |
| Sara Pirzadeh-Miller MS, CGC | None | None | None | None | ✔ |
| Donna Powell DHSc, CMD, RT(T) | None | None | None | None | - |
| Jewel Samadder MD | Cancer Insight Cancer Prevention Pharmaceuticals Janssen Pharmaceutica Products, LP |
Cancer Prevention Pharmaceuticals Guardant Janssen Pharmaceutica Products, LP One Two Therapeutics Recursion Pharmaceuticals |
None | None | ✔ |
| David Shibata MD, FACS, FASCRS | None | None | None | None | - |
| Peter Stanich MD | Emtora Biosciences Freenome Gaurdant Invitae Corp. Janssen Pharmaceutica Products, LP Pfizer Inc. PTEN Research foundation |
None | UpToDate, Inc. | Collaborative Group of the Americas on Inherited Gastrointestinal Cancers | ✔ |
| Benjamin Swanson MD, PhD | None | Cogen Bioscience | The France Foundation | Cogen Bioscience | ✔ |
| Brittany Szymaniak PhD, LCGC | None | "Technology-enhanced AcceleRation of Germline Evaluation for Therapy - The TARGET study" which has been funded by the Prostate Cancer Foundation. | UroGPO | None | ✔ |
| Jennifer Weiss MD, MS | Exact Sciences | None | American College of Physicians Medscape |
None | ✔ |
| Jeanna Welborn MD | None | None | None | None | - |
| Georgia Wiesner MD | None | None | None | None | ✔ |
| Andrew Wolf MD | None | None | None | None | - |
| Matthew Yurgelun MD | Janssen Pharmaceutica Products, LP | UpToDate | None | Facing Our Risk of Cancer Empowered (FORCE) advocacy group | ✔ |